Circulating Tumor Cells Are Associated with Poor Outcomes in Early-Stage Hepatocellular Carcinoma: A Prospective Study.
- Published in:
- Gut & Liver, 2019, v. 13, n. 6(suppl. 1), p. 89
- By:
- Publication type:
- Article
Works by Jun, Mi Jung
Results: 5
1
2
Correction to: Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
3
Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
4
Histological expression of methionine adenosyl transferase (MAT) 2A as a post‐surgical prognostic surrogate in patients with hepatocellular carcinoma.
- Published in:
- Journal of Surgical Oncology, 2018, v. 117, n. 5, p. 892, doi. 10.1002/jso.24994
- By:
- Publication type:
- Article
5
NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South Korea.
- Published in:
- Digestive Diseases, 2021, v. 39, n. 6, p. 634, doi. 10.1159/000514953
- By:
- Publication type:
- Article